Allergic rhinitis drugs market
Allergic Rhinitis Treatment Market, By Treatment Type (Immunotherapy (Sub-cutaneous Immunotherapy, Sub-lingual Immunotherapy), Anti-histamines, Decongestants, Leukotriene Receptor Antagonists, Corticosteroids, and Others), By Route of Administration (Oral, Nasal, Intraocular, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and E-commerce), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
- Apr 2024
- CMI1201
- 181 Pages
- Excel & Pdf
- Pharmaceutical
Summary
N/A
Table of Content
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Pipeline Analysis
- Epidemiology
- Acquisitions and Partnerships Scenario
- Product Launches/Approvals
- Brand and Pricing Analysis
- Funding and Investments
- PEST Analysis
- Porter’s Analysis
- Market Dynamics
- Global Allergic Rhinitis Treatment Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
- Global Allergic Rhinitis Treatment Market, By Treatment Type, 2019 – 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Immunotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Sub-cutaneous Immunotherapy (SCIT)
- Sub-lingual Immunotherapy (SLIT)
- Anti-histamines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Decongestants
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Leukotriene Receptor Antagonists
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Corticosteroids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Overview
- Global Allergic Rhinitis Treatment Market, By Route of Administration, 2019 – 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Nasal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Intraocular
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Overview
- Global Allergic Rhinitis Treatment Market, By Distribution Channel, 2019 – 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- E-commerce
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Overview
- Global Allergic Rhinitis Treatment Market, By Region, 2019 – 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019–2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GSK plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Johnson & Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Aytu BioPharma, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Regeneron Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Revolo Biotherapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Dr. Reddy’s Laboratories Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Glenmark Pharmaceuticals Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Alembic Pharmaceuticals Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Hikma Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck & Co., Inc.
- Company Profiles
- Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
- References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
*Browse 35 market data tables and 31 figures on "Allergic Rhinitis Treatment Market” - Global forecast to 2031
Segmentation
Detailed Segmentation-
- By Treatment Type:
- Immunotherapy
- Sub-cutaneous Immunotherapy (SCIT)
- Sub-lingual Immunotherapy (SLIT)
- Anti-histamines
- Decongestants
- Leukotriene Receptor Antagonists
- Corticosteroids
- Others
- Immunotherapy
- By Route of Administration:
- Oral
- Nasal
- Intraocular
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- E-commerce
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Frequently Asked Questions -
What will be the CAGR of the allergic rhinitis treatment market?
The CAGR of the allergic rhinitis treatment market is projected to be 4.9% from 2024 to 2031.
What are the major factors driving the allergic rhinitis treatment market growth?
Increasing availability of allergen immunotherapy solutions and increasing prevalence of allergic rhinitis are the major factor driving the growth of the allergic rhinitis treatment market.
What are the key factors hampering the growth of the allergic rhinitis treatment market?
Termination of the clinical trial study and the preference for alternative treatment approaches like natural and homeopathic remedies are the major factors hampering the growth of the allergic rhinitis treatment market.
Which is the leading treatment type in the allergic rhinitis treatment market?
In terms of treatment type, immunotherapy is estimated to dominate the market revenue share in 2024.
Which are the major players operating in the allergic rhinitis treatment market?
Merck & Co., Inc., Boehringer Ingelheim International GmbH, AstraZeneca, GSK plc., Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Aytu BioPharma, Inc., Regeneron Pharmaceuticals Inc., Revolo Biotherapeutics, Dr. Reddy’s Laboratories Ltd, Glenmark Pharmaceuticals Ltd, Bayer AG, Alembic Pharmaceuticals Limited, Sanofi, and Hikma Pharmaceuticals PLC are the major players.
Which region will lead the allergic rhinitis treatment market?
North America is expected to lead the allergic rhinitis treatment market.